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Purpose: The aim of this study was to investigate feasibility of exercise-based rehabilitation delivered after hos-
pital discharge in patients with intensive care unit–acquired weakness (ICU-AW).
Materials and methods: Twenty adult patients, mechanically ventilated for more than 48 hours, with ICU-AW diag-
nosis at ICUdischargewere included in a pilot feasibility randomized controlled trial receiving a 16-session exercise-
based rehabilitation program. Twenty-one patients without ICU-AW participated in a nested observational cohort
study. Feasibility, clinical, and patient-centered outcomes were measured at hospital discharge and at 3 months.
Results: Intervention feasibility was demonstrated by high adherence and patient acceptability, and absence of ad-
verse events, but this must be offset by the low proportion of enrolment for those screened. The study was under-
powered to detect effectiveness of the intervention. The use of manual muscle testing for the diagnosis of ICU-AW
lacked robustness as an eligibility criterion and lacked discrimination for identifying rehabilitation requirements.
Process evaluationof the trial identiﬁedmethodological factors, categorizedby “population,” “intervention,” “control
group,” and “outcome.”
Conclusions: Important data detailing the design, conduct, and implementation of a multicenter randomized con-
trolled trial of exercise-based rehabilitation for survivors of critical illness after hospital discharge have been reported.
Registration: Clinical Trials Identiﬁer NCT00976807
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Peripheral skeletal muscle wasting and dysfunction are major com-
plications of critical illness, both occurring early and progressing rapidly
[1]. The resulting intensive care unit–acquired weakness (ICU-AW) is a
major factor contributing to “post–intensive care syndrome” evident in
survivors [2]. Although there are data to support the use of exercise
therapy to address physical deconditioning within the ICU [3–8] and
after transfer to the ward [9–11], the clinical beneﬁt beyond hospital
discharge is controversial, and therefore, the delivery of such a servicethe National Institute for Health
d St Thomas' NHS Foundation
ose of the author(s) and not nec-
R or the Department of Health.
tory Unit Patient Association.
of interest.
t Thomas' Hospital,Westminster
.
olly).
. This is an open access article underhas been inconsistent. In the UK, despite the high proﬁle of this area
and publication of guidelines from the National Institutes of Health
and Care Excellence [12], we have recently shown that there is lack of
available services for post–critical illness patients [13]. Indeed, a paucity
of evidence, including randomized controlled trial (RCT) data [14], to
underpin these guidelineswas identiﬁed as a barrier to their implemen-
tation [13]. Speciﬁcally, 3 recent interventional trials demonstrated little
or no clinical beneﬁt [9,15,16]. Interestingly, however, while methodo-
logical variation in the delivery of the intervention across these studies
could have contributed to these results, none of these trials stratiﬁed pa-
tients by presence of ICU-AW or peripheral muscle wasting as an inclu-
sion criterion, and thus, the target population may have been less likely
to beneﬁt from the intervention. Diagnosis of ICU-AW, measured by
manual muscle testing, has previously been shown to demonstrate a
causal association with poor clinical outcome [17–24], and therefore,
these patients may have greater ongoing rehabilitation requirements.
This pilot trial investigated (1) the feasibility of an exercise-based re-
habilitation program (EBRP) delivered after hospital discharge in pa-
tients with ICU-AW and (2) the clinical use of ICU-AW diagnosis as an
eligibility criterion for enrolment. In addition, a nested observationalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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deﬁne the trajectory of recovery of such patients.
2. Materials and methods
2.1. Ethical approval
Ethical approval was obtained from London Westminster Research
Ethics Committee (London, UK, 09/H0802/80), and local Research &De-
velopment site-speciﬁc approval from participating organizations.
Written informed consent was obtained from all participants.
2.2. Study design
A pilot feasibility RCT of exercise rehabilitation was conducted in
survivors of critical illness with ICU-AWwith a nested parallel observa-
tional cohort study of post–critical illness patients without ICU-AW. Be-
cause of the pilot, feasibility nature of the study, there was no a priori
calculated sample size.
2.3. Patients
Patientswere recruited from the ICUs of 2 London teaching hospitals
within an Academic Health Sciences Centre (60 beds in total). One hos-
pital is a regional trauma and neurosciences center, and the other a ter-
tiary referral center for advanced ventilation,with bothhaving a general
medical and surgical case mix.
2.4. Screening
All patients receiving mechanical ventilation (MV) during their ICU
admission were screened for potential eligibility. Screening occurred
over 6 sessions per week depending on availability of the research
team. Participants were approached for recruitment at ICU discharge,
and consenting patients were randomized into either standard care or
intervention groups if they had evidence of ICU-AW as per deﬁni-
tion [18]. If ICU-AWwas not present, patientswere enrolled into the ob-
servational study within 24 hours of ICU discharge.
2.5. Inclusion criteria
Inclusion criteria for enrolment included age 18 years or more, MV
for 48 hours or more, Glasgow Coma Scale 15/15, survival to hospital
discharge, and sufﬁcientmobility to participate in an EBRP after hospital
discharge. Speciﬁcally for inclusion into the RCT, participants were re-
quired a diagnosis of ICU-AWat ICU discharge. Participants in the obser-
vational cohort study did not demonstrate ICU-AW.
2.6. Exclusion criteria
Patients were excluded if they were palliative, had unstable cardiac
disease, had limb amputation, neurological diagnoses, had peripheral
vascular disease awaiting revascularization, had any musculoskeletal
condition or extensive medical comorbidity precluding ability to exer-
cise, had psychiatric illness, had requirement for ongoing renal dialysis,
were an extracontractual referral and could not return to the hospital
site, or had an existing rehabilitation pathway in place.
2.7. Assessment of ICU-AW
Assessment of ICU-AW was conducted as described previously
[17,18,20] by the lead researcher. Adequate conscious level of patients
was determined as a score of−1 (drowsy) to+1 (restless) on the Rich-
mond Agitation Sedation Scale [25]. Awake patients were then required
to demonstrate positive response to a battery of simple one-stage com-
mands including “Open and close eyes” and “Stick out your tongue.”Successful completion of these commands was followed by muscle
strength assessment using the Medical Research Council Sum score
(MRC-SS), a 6-point grading scale ranging from 0 (no visible contrac-
tion) to 5 (normal power) applied to 6 upper and lower limb muscle
groups bilaterally (shoulder abduction, elbow ﬂexion, wrist extension,
hip ﬂexion, knee extension, and ankle dorsiﬂexion) [26]. The ICU-AW
was deﬁned as an MRC-SS of less than 48 out of 60 [17,19,27–29].
2.8. Randomization
Randomization was managed by the Mental Health and Neurosci-
ence Clinical Trials Unit (London, UK) (see Online Supplement
Section E1 for further detail). Treatment allocation was undertaken in-
dependently of the research team. Once notiﬁed of treatment allocation
by the Clinical Trials Unit, participants and relevant treating clinicians
were informed. Because of the pilot status of the RCT and the nature
of the therapy intervention, blinding of participants and the research
team was not possible.
2.9. Intervention
Patients randomized to the intervention arm of the RCT completed
an EBRP after hospital discharge. Full details of the intervention are de-
tailed in the online supplement (Section E2). In brief, the EBRP is com-
posed of 16 sessions of 40 minutes' duration, including warm-up and
cool-down periods and a combination of cardiovascular, upper and
lower limb strength, balance, and functional exercises individually tai-
lored for patients. Sessions occurred twice weekly, in an outpatient
physiotherapy gymnasium, supervised by members of the research
team. Successful completion of the EBRP was deﬁned a priori as atten-
dance at greater than or 50% of sessions, as per local pulmonary rehabil-
itation practice [30], and participants were required to complete
acceptability questionnaires at completion. The EBRP was delivered
over a 3-month period to allow for other clinical commitments or fac-
tors resulting in patient nonattendance. Patients were strongly encour-
aged to undertake 1 independent exercise session per week using an
accompanying exercise manual to guide and record this. The EBRP
contained an informal education component where participants were
invited to attend sessions covering breathlessness management, bene-
ﬁts of exercise, and nutrition. Furthermore, the research teamwas avail-
able to provide one-to-one advice for participants as required.
2.10. Standard care arm and observational study
Patients randomized to the standard care arm or enrolled into the
observational cohort study received a weekly telephone call from the
research team to monitor general progress of recovery. Although in ex-
cess of routine standard care, this was mandated by the ethical review
board. There was no speciﬁc advice on exercise rehabilitation provided
during these telephone calls.
2.11. Core outcome measures
Outcome measures for both the RCT and observational study were
assessed at baseline (hospital discharge) and at 3 months (Fig. 1) and
included (1) exercise capacity—Incremental Shuttle Walk Test (ISWT)
[31] and Six Minute Walking Test (6MWT) [32]; and (2) health-
related quality of life—Short Form 36 v.2 questionnaire (SF-36, Acute
Recall version) [33] physical (PCS) andmental (MCS) component scores
and the Hospital Anxiety and Depression Scale (HADS) [34]. Feasibility
outcomes, including screening, eligibility and recruitment rates, adher-
ence to the EBRP, duration of exercise, information to guide education
provision, results across a range of outcome measures, and clinical data
associatedwith the ICU staywere collected and analyzed. Additional out-
come measures are detailed in the online supplement (Section E3).
Fig. 1. Schematic outline of pilot RCT andobservational study pathway. *Note that patients in the observational study did not undergo randomization butweremanaged in the sameway as
the control group of the RCT.
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All data are expressed as mean± SD or median (interquartile range
[IQR]) as appropriate. Appropriate comparative tests were applied to
determine within-group and between-group differences in both the
pilot RCT and observational studies. For analyses between the random-
ized cohort with ICU-AW and the observational cohort without
ICU-AW, these were limited to outcomes related to physical perfor-
mance based on the rationale that these had the potential to be more
inﬂuenced by degree of global peripheral skeletal muscle strength.
3. Results
3.1. Feasibility of the exercise-based rehabilitation intervention in patients
with ICU-AW
3.1.1. Recruitment to a pilot feasibility RCT
Patients were recruited between February 2010 and May 2012 with
follow-up completed by August 2012. Participant ﬂow-through is de-
scribed in the Consolidated Standards of Reporting Trials [35] diagram
(Fig. 2). A large proportion of all potentially eligible patients were exclud-
ed (n = 743), 10 of whom declined consent (Table 1). Further detail on
the hospital discharge outcomes of excluded patients and interpretation
of eligibility criteria are reported in the online supplement (Section E4).
Twenty patients provided informed consent. These data indicate that 37
eligible patients were approached for 1 patient to be successfully recruit-
ed, albeit the logistics of screening across 2 study sites may have inﬂu-
enced this ratio. Consent rate in approached patients was 66.7% (20 of
30). Ten patients were randomized into each trial group. Baselinecharacteristics of the cohort are reported in Table 2. The groupswere sim-
ilar for all characteristics. MRC-SS for the cohort with ICU-AW was 43.0
(39.0-44.8).
3.1.2. Adherence to the EBRP
Of the 10 patients randomized to receive the EBRP, 8 successfully
completed the intervention with 16.0 (9.3-16.0) sessions attended. Of
the 2 patients who failed to complete the program, 1 attended only
once due to recurrent chest infections with a subsequent reluctance to
continue with the intervention. The second patient attended 7 sessions
but was unable to continue participation due to a general deterioration
in health related to a separate illness diagnosis (Addison's disease). For
2 of the 8 patients who, by deﬁnition, successfully completed the inter-
vention, the reasons for not attending all 16 sessions included seasonal
chest infections, family circumstances, and separate clinical appoint-
ments necessitating hospital attendance.
3.1.3. Adverse events
There were no adverse events during any of the EBRP sessions. One
patient in the intervention arm was admitted to hospital for investiga-
tion of cardiac symptoms occurring outside of the program, which
were unrelated to exercise participation. On discharge, this patient
wasmedically approved to resume full participation in the intervention.
3.1.4. Patient exercise time per session
Within each session of the EBRP, patients could exercise for 25minutes
(total 40 minutes with warm-up and cool-down time). Patient exercise
time per sessionwas 21.9 (20.9-23.4)minutes,which remained consistent
with the exclusion of noncompleters (21.9 (21.0-23.2) minutes.
Fig. 2. Consolidated standards of reporting trials diagram detailing patient ﬂow-through within the RCT.
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Patients attended an average of 5 education sessions. Individual advice
was also provided by the research teamwhere necessary. It was therefore
not possible to quantify or analyze this input in a standardized manner.
3.1.6. Patient acceptability
Of the 8 patients successfully completing the EBRP, 6 completed a sim-
ple acceptability questionnaire requesting their opinionon the experience
of participation with regard to the exercise component, and both the for-
mal (classes) and informal (individual advice provided by research team)
education sessions (Table 3). All 6 patients reported that, overall, they
were “very satisﬁed”with the program and that it had assisted their re-
covery after their illness. Furthermore, all patients reported greater un-
derstanding and knowledge around exercise participation, and that
increasing their ﬁtness levels had assisted in performance of activities ofdaily living. Only 1 patient reported that attendance at the hospital for
the EBRP was “too tiring.” Further details on patient acceptability of the
EBRP are reported in the online supplement (Section E5).
3.1.7. Core outcomes
All patients in the interventiongroupand6patients in the standard care
group completed follow-up at 3 months (Fig. 2). Results of outcome mea-
sures are reported in Table 4 and in the online supplement (Section E6).
Therewerenobetween-groupdifferences at baseline, change frombaseline
or at completion of the trial. Where minimum clinically important differ-
ence (MCID) data were available, both the intervention and the standard
care group improved beyond these limits. This included 47.5 m for the
ISWT [36] and 54 m for the 6MWT [37], albeit these data are established
for chronic respiratory disease populations. Interestingly, but not unexpect-
ed, none of the patients achieved their predicted distance for 6MWT at
Table 1
Factors accounting for ineligibility into the RCT
Factor Frequency of
occurrence (%)
Classiﬁcation
Ventilation ≥48 h 294 (39.6) Inclusion criterion not met
Extracontractual tertiary referral 185 (24.9) Exclusion criterion met
MRC-SS b48/60 132 (17.8) Inclusion criterion not met
Existing rehabilitation pathway 131 (17.6) Exclusion criterion met
Sufﬁcient mobility 97 (13.1) Inclusion criterion not met
ICU admission ≥48 h 95 (12.8) Inclusion criterion not met
Expected survival to hospital
discharge
93 (12.5) Inclusion criterion not met
Palliative/terminal prognosis 89 (12.0) Exclusion criterion met
Complex medical comorbidity 82 (11.0) Exclusion criterion met
Disabling condition precluding
exercise
80 (10.8) Exclusion criterion met
Unstable cardiac diagnoses 75 (10.1) Exclusion criterion met
Neurological diagnoses 64 (8.6) Exclusion criterion met
Impaired GCS 42 (5.7) Exclusion criterion met
Psychiatric diagnoses 42 (5.7) Exclusion criterion met
Ongoing renal haemodialysis 32 (4.3) Exclusion criterion met
Acute limb amputation 13 (1.7) Exclusion criterion met
Acute peripheral vascular disease 5 (0.7) Exclusion criterion met
Age N18 y 4 (0.5) Inclusion criterion not met
Data are presented as number (percentage), and report frequency of reported occurrence
of each criterion; therefore. total percentages exceed 100% (n = 733). Multiple factors
could apply per patient. GCS indicates Glasgow Coma Scale.
Table 3
Items and responses from patient acceptability questionnaire in the pilot RCT
Item Responses
1. Attending the exercise program
helped recovery from my illness
66.7% strongly agree, 33.3% agree
2. I have a clear picture of how
exercise will help my ﬁtness
66.7% strongly agree, 33.3% agree
3. I have a clear picture of how
ﬁtness will help in daily activities
of my life
66.7% strongly agree, 33.3% agree
4. I feel conﬁdent doing exercise 66.7% strongly agree, 33.3% agree
5. I worry that exercise may be
harmful to me
33.3% strongly disagree, 66.7% disagree
6. I felt very stressed doing the
exercise
33.3% strongly disagree, 66.7% disagree
7. I found the visits to the hospital
too tiring
50% strongly disagree, 33.3% disagree,
16.7% agree
8. Exercise has not helped me 66.7% strongly disagree, 33.3% disagree
9. The way the information
was presented
16.7% very satisﬁed, 66.7% satisﬁed,
16.7% unable to comment
10. The information given 16.7% very satisﬁed, 66.7% satisﬁed,
16.7% unable to comment
11. The opportunities you had to
discuss any concerns
16.7% very satisﬁed, 66.7% satisﬁed,
16.7% unable to comment
12. The way the staff answered
your questions
33.3% very satisﬁed, 50% satisﬁed,
16.7% unable to comment
13. The range of education
topics covered
16.7% very satisﬁed, 50% satisﬁed,
16.7% neither satisﬁed or dissatisﬁed,
16.7% unable to comment
Data from 6 patients successfully completing the EBRP. Items 1 to 8 refer to exercise compo-
nent of program. Items 9 to 13 refer to both formal and informal education sessions. Where
response indicates “Unable to comment,” this patient did not attend any education sessions.
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(459.8-536.5 m), and percent predicted 6MWT achieved was 66.4%
(46.2%-89.1%). By hospital discharge, commencement of the EBRP, the
MRC-SS of the randomized cohort was 56.0 (52.0-58.0), increasing to 60.0
(56.0-60.0) at completion, indicating that thesepatientsno longer exhibited
ICU-AW, as measured by the MRC-SS threshold of b48/60.
3.2. Natural recovery of post critical illness patients without ICU-AW
3.2.1. Recruitment to an observational cohort study
Failure to meet the inclusion criterion of demonstrating an MRC-SS
b48/60, that is, a diagnosis of ICU-AW, was evident in 132 of the 743 in-
eligible patients. Of these 132 patients, 21 met all other eligibility
criteria and consented to participate in the observational follow-upTable 2
Baseline characteristics for standard care and intervention arms of the pilot RCT and the obser
Characteristic Standard care group
(n =10)
Intervention group
(n =10)
Pooled ran
(n = 20)
Age (y) 68.5 (64.3-78.0) 63.0 (46.8-71.8) 66.5 (54.5-
Sex (male/female) 3:7 3:7 6:14
ICU diagnosisa (%)
Medical 6 (60) 7 (70) 13 (65)
Surgical 4 (40) 3 (30) 7 (35)
Chronic diseasea (%)
Respiratory 4 (40) 7 (70) 11 (55)
Cardiac 5 (50) 4 (40) 9 (45)
Otherb 5 (50) 3 (30) 8 (40)
APACHE II 23.5 (21.0-30.3) 24.5 (18.8-29.5) 23.5 (20.3-
SOFA (ICU admission) 12.0 (7.5-14.3) 9.5 (8.0-12.5) 11.0 (8.0-1
Duration MOF (days) 10.5 (5.8-13.3) 9.5 (6.8-15.3) 10.0 (6.0-1
MV (d) 11.2 (6.0-15.2) 9.3 (6.0-13.9) 10.2 (6.8-1
CPAP (d) 2.0 (0.3-4.6) 1.3 (0.04-6.9) 1.3 (0.2-5
Tracheostomy (%) 3 (30) 5 (50) 8 (40)
ICU LOS (d) 13.0 (9.8-20.5) 14.5 (7.0-17.8) 13.5 (8.5-1
CC LOS (d) 18.0 (13.8-36.5) 17.5 (9.0-27.3) 18.0 (11.5-
Ward LOS (d) 27.5 (10.0-46.3) 20.0 (10.0-43.0) 23.5 (10.3-
Hospital LOS (d) 47.5 (26.5-68.5) 39.0 (22.3-66.5) 46.0 (25.0-
Data are presented asmedian (IQR) or number (percentage). Standard care and intervention gro
fromMann-Whitney test or Fisher exact test~ and reﬂect difference between pooled data from
cohort. Note: 1 P value applicable for contingency analysis of proportion of medical and surgica
uation; SOFA, Sequential Organ Failure Assessment; MOF, multiorgan failure; CPAP, continuou
a ICU diagnosis and chronic disease indicates frequency of occurrence. Patients could presen
b Other chronic comorbidities included diabetes mellitus, osteoarthritis/gout, stable chronicstudy of patients without ICU-AW (Fig. 3). One patient was unable to
complete any baseline testing during the hospital stay due to lack of
availability for testing and was therefore withdrawn. A further 6 pa-
tients did not complete the study. Baseline characteristics for the obser-
vational cohort are reported in Table 2. MRC-SS for the group at
enrolment at ICU discharge was 56.5 (53.3-59.8).
3.2.2. Core outcomes
Results in outcomemeasures for the observational cohort are present-
ed in Table 5 and the online supplement (Section E7). Improvementsvational cohort study
domized cohort (ICU-AW) Observational cohort (MRC-SS ≥48/60)
(n = 21)
P
73.3) 63.0 (49.5-70.0) .3
16:5 .005~
15 (71.4) .7~
6 (28.6) n/a
7 (33.3) .07~
7 (33.3) .2~
10 (47.6) .8~
29.5) 17.0 (12.5-19.5) b .0001
3.5) 10.0 (7.5-12.0) .4
2.8) 9.0 (3.5-14.5) .6
4.0) 9.0 (4.3-20.4) 1.0
.0) 1.5 (0.4-2.6) .6
8 (38.1) –
9.3) 10.0 (6.5-27.0) .9
31.8) 13.0 (10.0-37.0) .8
43.0) 13.0 (6.5-19.5) .03
61.8) 30.0 (19.5-47.5) .2
upswere similar for all characteristics (all P=ns therefore not reported). P values derived
groups within the randomized cohort with ICU-AW and the clinically strong observational
l patients across both groups. APACHE indicates acute physiology and chronic health eval-
s positive airway pressure; LOS, length of stay; CC, critical care.
t with more than 1 comorbidity.
renal disease.
Table 4
Results of outcome measures assessed in the pilot RCT
Outcome measure Standard care (n = 6) Intervention (n = 10)
Baseline Completion Change Baseline Completion Change
ISWT (m) 20.0 (10.0 to 60.0) 190.0 (70.0 to 355.0) 170.0 (40.0 to 315.0) 55.0 (7.8 to 120.0) 200.0 (132.5 to 340.0) 115.0 (−2.5 to 237.5)
6MWT (m) 150.0 (100.5 to 207.0) 335.0 (177.5 to 455.0) 185.0 (40.0 to 285.0) 180.0 (125.0 to 221.5) 328.5 (230.0 to 393.8) 140.0 (35.8 to 210.3)
SF-36 v2 PCS (/100) 20.6 (19.4 to 33.3) 42.3 (27.9 to 47.6) 11.0 (4.3 to 28.3) 29.8 (24.1 to 33.2) 33.2 (23.8 to 45.4) 1.8 (−6.8 to 15.9)
SF-36 v2 MCS (/100) 50.9 (35.6 to 57.8) 45.6 (34.3 to 54.7) −11.4 (−19.0 to 19.1) 31.6 (28.6 to 49.1) 53.4 (39.5 to 58.8) 14.3 (−3.2 to 26.7)
HADS total (/42) 14.0 (9.0 to 20.0) 6.5 (5.5 to 10.3) −4.5 (−13.3 to−2.5) 13.0(7.0 to 19.0) 9.0 (3.5 to 10.3) −6 (−9.3 to−2.8)
HADS anxiety (/21) 6.0 (1.5 to 11.5) 4.0 (0.8 to 6.0) 0.0 (−7.0 to 0.0) 7.0 (4.5 to 9.3) 4.0 (1.8 to 5.5) −3.5 (−5.0 to−1.3)
HADS depression (/21) 8.5 (7.3 to 10.0) 2.5 (2.0 to 8.0) −4.5 (−6.3 to−1.8) 5.5 (2.8 to 11.0) 4.5 (1.0 to 7.3) −1.5 (−3.3 to 2.0)
Data are presented as median (IQR).
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for each test [36,37]. Predicted 6MWTdistance at completion for the cohort
was 552.0 m (480.2-621.6 m), and percent predicted distance achieved
was 74.4% (58.0%-93.5%). Improvements were also observed in health-
related quality of life between baseline and completion (SF-36 PCS, 34.0
[28.2-41.4] to 42.7 [35.7-48.5], P = .01; SF-36 MCS, 44.4 [34.9-52.6] to
51.4 [43.1-57.2], P= .03). MRC-SS for the observational cohort at hospital
discharge was 60.0 (57.0-60.0), and at completion, 60.0 (60.0-60.0).
3.3. Recovery of patients with ICU-AW and those without ICU-AW
Comparison of baseline characteristics between the randomized co-
hort with ICU-AW and the observational cohort without ICU-AW is pre-
sented in Table 2. The male-to-female ratio was greater in the
observational cohort (P = .005). Patients with ICU-AW were sicker atFig. 3. Flow diagram detailing participant ﬂow throughICU admission, with signiﬁcantly higher illness severity (Acute Physiol-
ogy and Chronic Health Evaluation II) scores than those without ICU-
AW (23.5 [20.3-29.5] vs 17.0 [12.5-19.5], P b .0001). Furthermore,
these patients experienced a longer post ICU in-hospital ward stay
(23.5 [10.3-43.0] days vs 13.0 [6.5-19.5] days, P = .03), but only a
trend to extended total hospital stay (46.0 (25.0-61.8] days vs 30.0
[19.5-47.5], P= 0.2).
3.3.1. Core outcomes
Comparison of the outcomes between groups is summarized in
Table 6. There were no consistent between-group differences at base-
line and completion of the study. Furthermore, there was no difference
in baseline to completion change. However, at a group level, patients
without ICU-AW demonstrated greater ISWT distances at completion
(365.0 m [250.0-477.5 m] vs 200.0 m [120.0-330.0 m], P= 0.03), withobservational study of clinically strong patients.
Table 5
Results of outcome measures assessed in the observational cohort study
Outcome measure Baseline Completion Change P
ISWT (m) 80.0 (30.0 to 212.5) 365.0 (250.0 to 477.5) 265.0 (207.5 to 300.0) .0002
6MWT (m) 167.0 (60.0 to 293.5) 433.5 (318.3 to 481.0) 157.5 (131.3 to 321.3) .0002
SF-36 v2 PCS (/100) 34.0 (28.2 to 41.4) 42.7 (35.7 to 48.5) 6.4 (1.7 to 13.1) .01
SF-36 v2 MCS (/100) 44.4 (34.9 to 52.6) 51.4 (43.1 to 57.2) 4.7 (−1.8 to 11.4) .03
HADS
Total (/42) 10.0 (6.8 to 14.0) 9.0 (6.5 to 13.0) 0.5 (−3.3 to 4.5) .8
Anxiety (/21) 5.0 (3.0 to 7.5) 4.0 (2.8 to 8.3) 0.0 (−2.0 to 3.3) .7
Depression (/21) 5.5 (2.8 to 7.3) 5.5 (1.8 to 7.5) 1.0 (−2.5 to 3.3) .8
Data are presented as median (IQR) (n = 14). P values derived fromWilcoxon signed rank test and reﬂect change from baseline to completion.
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= .047). In addition, there was a higher SF-36 PCS (34.0 [28.2-41.4] vs
29.4 [19.7-32.9], P = .03) and SF-36 physical function domain (40.0
[15.0-66.3] vs 12.5 [5.0-27.5], P= .005) in those patients without ICU-
AW at baseline, although this between-group difference was not pres-
ent at completion. Patientswithout ICU-AWhad enhanced physical per-
formance as measured by the Timed Up And Go test at baseline (14.8
[13.1-18.5] vs 21.0 [16.0-36.0], P= .04), but there were no differences
between the groups observed in the Barthel and Sit to Stand 5 tests.3.3.2. Relationship between ICU-AW and physical function
Extended analyses of the relationship between ICU-AWand physical
function performance at study milestones is shown in the on line sup-
plement (Sections E8).3.3.3. Sample size
The calculated sample sizes for a future trial are reported in the on-
line supplement (Section E9).Table 6
Comparison of outcome measures between patients with ICU-AW and clinically strong
patients
Characteristic Randomized cohort
(ICU-AW) (n = 16)
Observational cohort
(MRC-SS ≥48/60) (n = 14)
P
ISWT (m)
Baseline 40 (10.0 to 80.0) 80.0 (30.0 to 212.5) 0.1
Completion 200.0 (120.0 to 330.0) 365.0 (250.0 to 477.5) 0.03
Change 120.0 (10.0 to 230.0) 265.0 (207.5 to 300.0) 0.047
6MWT (m)
Baseline 160.0 (110.5 to 221.0) 167.0 (60.0 to 293.5) 0.8
Completion 330.0 (240.0 to 422.5) 433.5 (318.3 to 481.0) 0.1
Change 160.0 (36.5 to 208.5) 157.5 (131.3 to 321.3) 0.5
SF-36 PCS (/100)
Baseline 29.4 (19.7 to 32.9) 34.0 (28.2 to 41.4) 0.03
Completion 34.6 (46.5 to 55.1) 42.7 (35.7 to 48.5) 0.2
Change 6.3 (−3.2 to 16.2) 6.4 (1.7 to 13.1) 0.9
SF-36 PF (/100)
Baseline 12.5 (5.0 to 27.5) 40.0 (15.0 to 66.3) 0.005
Completion 40.0 (20.0 to 73.8) 70.0 (41.8 to 80.0) 0.1
Change 20.0 (0.0 to 60.0) 23.5 (3.8 to 31.3) 0.8
Barthel (/100)
Baseline 87.5 (75.0 to 95.0) 97.5 (85.0 to 100.0) 0.08
Completion 100.0 (86.3 to 100.0) 100.0 (98.8 to 100.0) 0.5
Change 10.0 (1.3 to 23.8) 0.0 (0.0 to 15.0) 0.2
TUAG (s)
Baseline 21.0 (16.0 to 36.0) 14.8 (13.1 to 18.5) 0.04
Completion 10.0 (8.0 to 19.0) 8.0 (6.8 to 10.0) 0.06
Change −7.0 (−24.0 to−2.0) −6.0 (−9.3 to−3.8) 0.6
STS-5 (s)
Baseline 22.5 (16.8 to 29.5) 19.0 (10.8 to 26.0) 0.3
Completion 16.0 (11.5 to 20.0) 11.4 (8.9 to 17.5) 0.2
Change −3.8 (−15.0 to 1.9) −3.5 (−11.0 to−0.5) 0.98
Data are presented as median (IQR). P values derived fromMann-Whitney test analysis. n
= 14 for TUAG and STS-5 for the randomized cohort. SF-36 v2 PF indicates Short Form-36
v2 Physical Function domain; TUAG, Timed Up and Go; STS-5, Sit to Stand 5 times.4. Discussion
This pilot RCT investigating exercise-based rehabilitation delivered
after hospital discharge in survivors of critical illnesswith ICU-AWdem-
onstrated that the intervention was feasible as evidenced by the high
completion rate, an absence of adverse events, and strong patient-
reported acceptability. However, the change in diagnostic status of
ICU-AW between patient enrolment and commencement of the inter-
vention indicates that using manual muscle testing for determining
presence of weakness lacked robustness as an eligibility criterion for
participation. Furthermore, the observation of the natural recovery of
patients without ICU-AW revealed inconsistent differences in outcomes
between this cohort and those patients with weakness, indicating that
stratiﬁcation for exercise rehabilitation requirements using this ap-
proach lacked satisfactory discrimination, which was demonstrated by
the ceiling effect of the MRC-SS test.
4.1. Clinical signiﬁcance of the ﬁndings
This study was not powered to detect differences between groups
across any of the clinical, mechanistic, and patient-centered outcomes,
and therefore cannot suggest effectiveness of the intervention limiting
comparison with ﬁndings from previously reported trials [9,15,16]. De-
spite this, speciﬁcation of a diagnosis of ICU-AW,measured by theMRC-
SS at ICU discharge as a speciﬁc eligibility criterionwas a novel aspect of
this pilot trial, based on the extensive data reporting a causal association
between anMRC-SS less than 48 and poor clinical outcome [17–23] and
the rationale for greater rehabilitation requirements. Although since
this trial was ﬁrst designed, use of theMRC-SS threshold for diagnosing
ICU-AW has been shown to lack both sensitivity and speciﬁcity to pre-
dict clinical outcome [39], in this study, the diagnosis ICU-AW failed to
deﬁne themost appropriate target group for an exercise-based rehabilita-
tion intervention. Indeed, at ICU discharge, patients with ICU-AW and
those without had similar baseline characteristics. By hospital discharge,
when the intervention commenced, those patients with ICU-AW at ICU
discharge had improved clinically, demonstrating an MRC-SS greater
than 48, such that they could be recategorized as without ICU-AW. This
ceiling effect limits the clinical usefulness of MRC-SS testing.
Presence of ICU-AW at ICU discharge did, however, alter the ward-
based therapy provision for these patients and inﬂuence their trajectory
of recovery during this period. These patients were the sickest patients
at ICU admission, and based on our previous data were those likely to
have undergone greater muscle wasting during the ﬁrst week of critical
illness [1]. It is postulated that the ward stay of such patients was
protracted while they received more intense rehabilitation interven-
tions than thosewithout ICU-AW to achieve a level of function sufﬁcient
for hospital discharge, at which point the MRC-SS could not distinguish
between the groups. Unfortunately, these datawere not captured in this
study, nor indeed were data regarding the dose of rehabilitation or
other ICU exposures received by patients during their preceding ICU
stay. Future trialsmust carefully characterize the pretrial period rehabil-
itation and other factors that could inﬂuence outcome and recovery in
patients, in detail [40].
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ments in exercise capacity and subjective physical function scores beyond
currently available MCID data, albeit speciﬁc values for the post–critical
illness population have yet to be established, and we acknowledge
these were pilot patient numbers. However, natural recovery exceeding
the current MCID has clinical relevance, and it is important to note as
any future rehabilitation intervention would need to demonstrate effec-
tiveness beyond this level. In addition, the rate of recovery trajectory
also requires consideration to deliver the intervention at the optimal
time point during recovery. MCID data for outcomes should be applicable
to the relative stage of recovery, as thiswill ultimately inﬂuence the effect
of the intervention. Satisfactory recovery with standard management in
the early recovery period could result in resource allocation to the later
stages of the patient pathway when there is a greater clinical need.
4.2. Critique of the method
Process evaluation can distinguish failure of an intervention to cause
an effect from failure of effective delivery of the intervention [41,42] and
is integral to the development, evaluation, and reporting of complex in-
terventional trials [43], such as exercise rehabilitation in the post–criti-
cal illness population. The pilot nature of this trial precluded detecting
effectiveness of the intervention, and so, we focused on retrospective
evaluation of methodological considerations around trial design, an im-
portant feature and outcome associatedwith pilot trials [44]. Undertaking
this process is a particular strength of this feasibility study, informing our
understanding of aspects that would require consideration in a future,
larger scale study. We adopted the population, intervention, control,
and outcome construct, so called “PICO” principle, to assess the present
trial and provide a framework for discussion [45,46].
4.2.1. Population
Heterogeneity of post–critical illness patients challenges the deliv-
ery and evaluation of rehabilitation throughout the recovery pathway,
with individual patterns of response to interventions evident. Trial eligi-
bility criteria aim to enrol more homogenous cohorts, and those
adopted in this studywere consistentwith previous trials. This resulted,
however, in an extremely low ratio of included to excluded patients and
indeed has attributed to failure to reach a priori sample sizes in prior
larger scale studies [9,16]. Further deﬁnition of the patients most likely
to beneﬁt from post–hospital discharge rehabilitation is required [47] to
maximize recruitment. Experience from this study challenges the use-
fulness of measuring peripheral skeletal muscle strength using manual
muscle testing.Measures of physical functional performance that reﬂect
residual impairment are more likely to be useful, but require validation.
The severity of the acute critical illness determines the degree of skeletal
muscle wasting, and the presence of preexisting chronic disease states
determines the trajectory of the recovery pathway, and both need to
be considered in any future trials [48]. Assessment for eligibility, ran-
domization, and commencement of the intervention should be synchro-
nous to ensure that natural recovery is accommodated into the trial
design in both the control and intervention group, and the intervention
is being tested effectively. Furthermore, in light of greater recognition of
the cognitive affects associated with critical illness, in any future trial of
exercise-based rehabilitation, the cognitive ability of patients will need
to be assessed and delirium excluded along with the usual assesment
for mental capacity status'.
4.2.2. Intervention
Post–intensive care syndrome encompasses a range of physical, psy-
chological, cognitive, and physical impairments for survivors of critical
illness [2]. The current trial focused on an exercise-based intervention
primarily targeted toward physical recovery. The failure to address
othermorbidities of critical illness [47]may have contributed to the out-
come, although thiswould only be conﬁrmed by a fully powered trial. In
the future, multidisciplinary, multimodal rehabilitation programs mayelicit greater response through the synergistic effect of optimizing 1 ele-
ment on another, for example, physical performance and mental health.
The optimum exercise prescription to enhance physical recovery in
post–critical illness patients has yet to be determined. This pilot study
conformed with recommendations for nonpharmacological trials by
closely detailing the intervention [49]. Nonetheless, the chosen content,
format, and route of deliverymaynot have beenpreferable for all partic-
ipants. That said, high completion rates were evident, but we acknowl-
edge that this may have, in part, been inﬂuenced by the provision of
transport to and from the hospital, which may not always be available
in routine clinical practice. Clinical factors accounted for the majority
of nonattendances, which may also affect adherence to rehabilitation
delivered via other formats.
Because this is a pilot feasibility trial, future studies are required to test
if the current exercise prescriptionwould be sufﬁcient to cause physiolog-
ical improvement in a larger sample, evenwith the employment of target
intensity levels andmeasures formonitoring this.We delivered the inter-
vention in tandem with existing pulmonary rehabilitation programs for
patients with chronic respiratory disease for pragmatic and logistical rea-
sons, andwe acknowledge the inﬂuence of this in the design of our inter-
vention. Close attention is required to patient education in self-
monitoring of exercise and to individual exercise prescription and pro-
gression. Cardiopulmonary exercise testing could have a role in determin-
ing optimum exercise intensity and guiding exercise delivery, albeit
with pragmatic limitations for its frequentwidespread clinical availability
and implementation.
4.2.3. Standard care (control) group
Accurate description of the standard care or control arm in a com-
plex intervention trial is important for enhanced interpretation and
generalizability of the results [50,51]. Methods such as benchmarking
or point prevalence studies to detail and evaluate existing practice
have recently reported to the timing and intensity of exercise rehabilita-
tion in the ICU [52–54]. Standardized reporting of usual practice can im-
prove safety monitoring, facilitate and accelerate the translation of
research ﬁndings into local clinical practice, and enhance the under-
standing of differences between groupswith regard to intensity of inter-
ventions received [55,56].
In this study, the standard care arm received aweekly telephone call
from the research team, mandated by the ethical review board. While
no speciﬁc advice regarding exercise rehabilitationwas provided during
these phone calls, this represents additional input than these patients
would normally receive. Furthermore, standard care patients could
also be discharged from hospital in receipt of generic rehabilitation ser-
vices such as intermediate care or community therapy at the discretion
of the clinical team. Lack of formal evaluation of additional services re-
ceived by these patients represents a methodological weakness of the
current protocol. These interventions could have contributed to expe-
diting recovery, albeit given the small sample size this would not have
been possible to determine in the current trial.
4.2.4. Outcome measures
Various outcomemeasures are used in survivors of critical illness to
assess physical functional and performance, although the psychometric
properties of these tests have yet to be ascertained [57]. Indeed, appro-
priate outcome measures for evaluation of rehabilitation interventions
remain undetermined [47]. Outcome measures must be responsive to
change with close consideration for the relative ﬂoor and ceiling effects.
For complex intervention trials, a core outcome set may be required to
best reﬂect the response to an intervention, which would be applicable
to the speciﬁc stage of recovery [9]. In contrast, implementing such a
battery of assessmentmeasuresmaybedifﬁcult to achieve due to exces-
sive testing burden, and a clear balance between testing burden and ro-
bust outcome data must be found. In the current trial, we observed
“testing burden and measurement fatigue” potentially resulting in
poor test performance and missing data, which in a larger trial would
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to evaluate effectiveness of rehabilitation interventionswould guide future
trial protocols [58,59]. As this outcome set, there would also be a require-
ment to develop a speciﬁc bespoke post–critical illness tool to monitor re-
covery based on the qualitative assessment of patient experiences.
5. Conclusion
In this pilot trial, an EBRP after hospital discharge for survivors of
critical illness with ICU-AW was feasible in delivery and patient accep-
tance, albeit the study was underpowered to demonstrate intervention
effectiveness. Diagnosis of ICU-AW, based on results of manual muscle
testing, conferred limited clinical use as an eligibility criterion for partic-
ipation in such a rehabilitation program, and in identifying patients
most likely to beneﬁt from rehabilitation after hospital discharge. Pro-
cess evaluation identiﬁed methodological factors for consideration in
the design, conduct, and implementation of a future trial, notably fo-
cused on eligibility criteria, intensity, and timing of intervention deliv-
ery and appropriate outcomes for evaluating effectiveness.
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